An innovative market study on the “Global saliva-based Testing or Screening market” was recently added by a renowned research company, Cognizance Market Research. The study examines market growth opportunities and historical growth trends in order to provide useful insights for the forecast period of 2023 to 2030.
Global Saliva Based Testing or Screening Market Analysis:
The Global saliva-based Testing or Screening market is valued at US$ 324.6 Million and is anticipated to reach US$ 588.2 Million by the end of 2030 with CAGR of 7.7% from 2023 to 2030.
What is global saliva-based Testing or Screening market?
The saliva-based Testing or Screening refers to the diagnostic tests that analyse saliva samples for the presence of certain biomarkers or pathogens. Saliva-based Testing or Screening has emerged as a promising alternative to traditional methods of diagnostic testing, such as blood or urine analysis, due to its non-invasive nature, ease of collection, and potential for mass testing.
Saliva-based Testing or Screening is used in a variety of settings, including clinical diagnostics, infectious disease testing, genetic testing, and drug testing. It is also being used as a tool for monitoring and controlling the spread of infectious diseases, such as COVID-19, as it allows for rapid and non-invasive testing of large populations.
The global saliva-based Testing or Screening market is expected to experience significant growth in the coming years, driven by factors such as the increasing prevalence of infectious diseases, the growing demand for non-invasive diagnostic testing, and advancements in technology that have improved the accuracy and reliability of saliva-based tests.
Global Saliva Based Testing or Screening Market Outlook
The ongoing COVID-19 pandemic has accelerated the adoption of saliva-based Testing or Screening as a reliable and non-invasive method for diagnosing the virus. Governments, businesses, and organizations are increasingly relying on saliva-based tests for large-scale testing programs, which is expected to boost demand for these tests.
The increasing prevalence of chronic diseases such as diabetes and cancer is expected to drive demand for saliva-based Testing or Screening. These tests allow for early detection and monitoring of these diseases, which can improve patient outcomes and reduce healthcare costs.
Advances in technology are improving the accuracy and reliability of saliva-based tests, which is expected to drive adoption and demand. New developments in biosensors, microfluidics, and biomarkers are allowing for more sensitive and specific tests, which could have significant implications for disease diagnosis and monitoring.
The global saliva-based Testing or Screening market is expected to grow at a significant rate in the coming years, driven by the need for non-invasive and accurate diagnostic testing, as well as technological advancements and the growing prevalence of chronic diseases.
Test Type, application, collection method, end user and geography are the segments used to analyse the global saliva-based Testing or Screening market.
The global saliva-based Testing or Screening market is further divided into infectious diseases testing, drug testing, genetic testing, hormone testing other based on by test type. The applications for global saliva-based Testing or Screening market can be segmented into diagnostic, forensic investigation, drug testing, infectious disease testing.
Based on by collection type the global saliva based testing/ screening market is further bifurcated into hospitals, diagnostic laboratories, forensic laboratories, research institute, other. The end user for global saliva-based Testing or Screening market can be segmented into hospitals, diagnostic laboratories, forensic laboratories, research institute, other.
Geographically, there are five primary regions that make up the global saliva-based Testing or Screening: North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa. From a geographical perspective, North America is the largest market for saliva-based Testing or Screening, followed by Europe and the Asia Pacific. The high demand in North America is primarily driven by the growing need for non-invasive and cost-effective testing solutions, coupled with the increasing prevalence of chronic diseases in the region.
Europe is also a significant market for saliva-based Testing or Screening, driven by the growing demand for point-of-care testing solutions and the increasing focus on preventive healthcare. The Asia Pacific region is expected to witness the fastest growth in the market, driven by the increasing adoption of saliva-based Testing or Screening in countries such as China, India, and Japan.
The report offers the revenue of the global saliva-based Testing or Screening market for the period 2020-2030, considering 2020 & 2021 as a historical year, 2022 as the base year and 2023 to 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global saliva-based Testing or Screening market for the forecast period. The global saliva based Testing or Screening market report provides insights and in-depth analysis into developments impacting enterprises and businesses on a regional and global level. The report covers the global saliva-based Testing or Screening market performance in terms of revenue contribution from several segments and comprises a detailed analysis of key drivers, trends, restraints, and opportunities prompting revenue growth of the global saliva-based Testing or Screening market.
The report has been prepared after wide-ranging secondary and primary research. Secondary research included internet sources, numerical data from government organizations, trade associations, and websites. Analysts have also employed an amalgamation of bottom-up and top-down approaches to study numerous phenomena in the global saliva-based Testing or Screening market. Secondary research involved a detailed analysis of significant players’ product portfolio. Literature review, press releases, annual reports, white paper, and relevant documents have been also studied to understand the global saliva-based Testing or Screening market. Primary research involved a great extent of research efforts, wherein experts carried out interviews telephonic as well as questioner-based with industry experts and opinion-makers.
The report includes an executive summary, along with a growth pattern of different segmented included in the scope of the study. The Y-o-Y analysis with elaborate market insights has been provided in the report to comprehend the Y-o-Y trends in the global saliva-based Testing or Screening market. Additionally, the report focuses on altering competitive dynamics in the global market. These indices serve as valued tools for present market players as well as for companies interested in participating in the global saliva-based Testing or Screening market. The subsequent section of the saliva-based Testing or Screening market report highlights the USPs, which include key industry events (Type launch, research partnership, acquisition, etc.), technology advancements, pipeline analysis, prevalence data, and regulatory scenario.
Global Saliva Based Testing or Screening Market Competitive Landscape
With a focus on the global market, the “Global saliva-based Testing or Screening market ” study report will offer insightful information. Major companies are vying for market dominance in the highly competitive global saliva-based Testing or Screening market are as follows:
These businesses have substantial inventories of diabetic care goods, and they continually make investments in cutting-edge equipment and services to enhance patient results. While each company has its strengths, they also face strong competition from each other, which may make it challenging to maintain market share. Companies that can stay at the forefront of innovation and offer high-quality, effective products are likely to succeed in the global saliva-based Testing or Screening market.
The competitive environment of the global saliva-based Testing or Screening market is examined in the report. Major participants in the global saliva-based Testing or Screening market around the world have been found and profiled for their distinct commercial characteristics. The characteristics of the firms included in the global saliva-based Testing or Screening market study include a company overview (company description, type portfolio, geographic presence, employee strength, key management, etc.), financials, SWOT analysis, recent advancements, and key strategies.
Global Saliva Based Testing or Screening Market, by Test Type
Global Saliva Based Testing or Screening Market, by Application
Global Saliva Based Testing or Screening Market, by Collection Method
Global Saliva Based Testing or Screening Market, by End User
Global Saliva Based Testing or Screening Market, by Region
OraSure Technologies, Inc., Quest Diagnostics, Biocerna Corporation, Salimetrics, LLC, NeuMoDx Molecular, Inc., Clinical Reference Laboratory, Microbac Laboratories, Inc., VivaChek Biotech (Hangzhou) Co., Ltd., Vitro Diagnostic, Inc., Genesee Scientific Corporation, Bio-Rad Laboratories, Inc., Fluidigm Corporation, Transgenomic, Inc., DNA Genotek Inc., and Omni International, Inc.
Trends: The COVID-19 pandemic accelerated the adoption of saliva-based testing as an alternative to nasopharyngeal swabs. Saliva tests are less invasive, easier to self-administer, and may reduce the risk of exposure for healthcare workers.
Drivers: Saliva-based testing is less invasive than traditional blood tests or swab-based tests, making it more appealing to individuals, especially children and those with needle phobia.
Opportunities: There are opportunities to develop and market saliva-based tests for a wide range of diseases and conditions, including diabetes, cancer, autoimmune disorders, and more.
Challenges: Factors such as diet, hydration, and time of day can affect the composition and quality of saliva samples, potentially leading to variability in test results.
The CAGR is anticipated to be 7.7% during the forecast period.
The U.S. was at the forefront of developing and implementing saliva-based tests for COVID-19, including tests for diagnosis and surveillance. Several American companies and research institutions played a pivotal role in advancing this technology.
Saliva-based tests for cancer screening, early detection, and monitoring are gaining attention. These tests can detect biomarkers associated with various types of cancer, offering a non-invasive and potentially cost-effective alternative to traditional screening methods.
Get insights that lead to new growth opportunities
We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports
We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail